Anavex Life Sciences Corp (AVXL)

[polarbear77]

Logically, wouldn’t the 3-4 months of UNCONTROLLED and OPEN-LABEL Rett extension data since 6/25/19 have to be significantly positive (and biomarker and dose correlated) in efficacy & behavior for Drs Missling and Kaufmann to be comfortable enough to:

(1) broadcast in September through 3 different press releases the significantly positive and very encouraging Rett Syndrome results from
our 2-73 trial, and

(2) to present same in Finland at the European Rett Syndrome Conference for all in the worldwide Rett community to see and have their hopes raised?

They had months of open label data in their hands at that point.

I suppose it comes down to trust in the Company leadership/ethics and in Dr Kaufmann’s relationship with and expertise in this RS community and disease.

Do we really think they’d raise the hopes of this RS community carelessly or without just cause and without continuing strong open label data? I personally don’t think they would do that.

AIMHO